Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Gold IRA Companies
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Gold IRA Review
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
SYRE
Stock Latest News
The Fly
Spyre Therapeutics price target raised to $100 from $80 at Wedbush
17h ago
SYRE
Premium
Ratings
Spyre Therapeutics: Buy Rating Reaffirmed as Positive SPY002 Ulcerative Colitis Data Supports $103 Price Target
1d ago
SYRE
Premium
Ratings
Julian Harrison Reiterates Buy on Spyre Therapeutics, Lifts Price Target to $112 on Encouraging SPY002 Ulcerative Colitis Data and TL1A Platform Validation
1d ago
SYRE
Premium
The Fly
Spyre Therapeutics price target raised to $112 from $98 at BTIG
1d ago
SYRE
Premium
Company Announcements
Spyre Therapeutics Reports Strong Phase 2 SKYLINE Results
2d ago
8K
SYRE
Premium
The Fly
Spyre Therapeutics announces SKYLINE trial achieves primary endpoint
2d ago
SYRE
Premium
The Fly
Spyre Therapeutics price target raised to $115 from $102 at Deutsche Bank
13d ago
ABVX
SYRE
Premium
The Fly
Spyre Therapeutics completes enrollment in SKYWAY basket trial of SPY072
14d ago
SYRE
Premium
Company Announcements
Spyre Expands SPY003 Rights Beyond Inflammatory Bowel Disease
15d ago
8K
SYRE
Premium
Company Announcements
Spyre Therapeutics Shareholders Back Board, Governance Proposals
18d ago
8K
SYRE
Premium
The Fly
Spyre Therapeutics management to meet with BTIG
20d ago
SYRE
Premium
The Fly
Spyre Therapeutics price target raised to $102 from $86 at Deutsche Bank
1M ago
SYRE
Premium
The Fly
Spyre Therapeutics price target raised to $97 from $64 at Citi
1M ago
SYRE
Premium
The Fly
Spyre Therapeutics price target raised to $107 from $92 at Stifel
1M ago
SYRE
Premium
Ratings
Julian Harrison Reiterates Buy on Spyre Therapeutics, Maintains $98 Price Target on Strong IBD Pipeline and Cash Runway
1M ago
SYRE
Premium
Company Announcements
Spyre Therapeutics’ Exclusive Forum Clauses Shift Legal Leverage, Raise Venue and Litigation Cost Concerns for Stockholders
1M ago
SYRE
Premium
The Fly
Spyre Therapeutics reports Q1 EPS (74c), consensus (65c)
1M ago
SYRE
Premium
Ratings
Spyre Therapeutics: Buy Rating Reaffirmed as External Combo Data Support IBD Strategy; $95 Price Target Unchanged
2M ago
SYRE
Premium
The Fly
Spyre Therapeutics price target raised to $95 from $64 at JonesResearch
2M ago
SYRE
Premium
Company Announcements
Spyre Therapeutics Raises Capital Through Completed Stock Offering
2M ago
8K
SYRE
Premium
Market News
3 Best Trending Stocks, According to Analysts – 4/16/2026
2M ago
AMZN
GSAT
Premium
The Fly
Spyre Therapeutics 6.5M share Secondary priced at $62.00
2M ago
SYRE
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
